Will FDA approve Yellow No. 5 dye for non-invasive diagnostics by end of 2025? | Binary | | | 4 months ago | |
Will clinical trials using Stanford's nanoparticle adjuvant start by December 31, 2024? | Binary | | | 5 months ago | |
Will the FDA approve Stanford's nanoparticle adjuvant for use in vaccines by December 31, 2024? | Binary | | | 5 months ago | |
How many times will the transparent mice method be cited in scientific journals by end of 2024? | Categorical | | | 4 months ago | |
Will Stanford's nanoparticle adjuvant be incorporated in a COVID-19 vaccine by March 31, 2025? | Binary | | | 5 months ago | |
Which company will first license Stanford's nanoparticle adjuvant by June 30, 2025? | Categorical | | | 5 months ago | |
Which major conference will feature Stanford's transparent mice method by end of 2024? | Categorical | | | 4 months ago | |
Will another research institution replicate Stanford's transparent mice method by end of 2024? | Binary | | | 4 months ago | |
Will Stanford start human trials with Yellow No. 5 dye for non-invasive observation by September 2025? | Binary | | | 4 months ago | |
Which medical application will Stanford's transparent mice method be adopted for by end of 2025? | Categorical | | | 4 months ago | |
What will be the outcome of the Phase 1 clinical trial results for a vaccine using Stanford's nanoparticle adjuvant by June 30, 2025? | Categorical | | | 5 months ago | |
What will be the first disease targeted by a vaccine using Stanford's nanoparticle adjuvant by December 31, 2025? | Categorical | | | 5 months ago | |
